Fayez Sarofim & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.2M | Sell |
51,857
-438
| -0.8% | -$156K | 0.05% | 79 |
|
|
2025
Q4 | $17.1M | Buy |
52,295
+490
| +0.9% | +$155K | 0.04% | 90 |
|
|
2025
Q3 | $14.6M | Sell |
51,805
-341
| -0.7% | -$98.9K | 0.03% | 95 |
|
|
2025
Q2 | $14.6M | Buy |
52,146
+18,213
| +54% | +$5.16M | 0.03% | 97 |
|
|
2025
Q1 | $10.6M | Buy |
33,933
+1,116
| +3% | +$330K | 0.03% | 101 |
|
|
2024
Q4 | $8.55M | Buy |
32,817
+8,215
| +33% | +$2.44M | 0.02% | 106 |
|
|
2024
Q3 | $7.93M | Buy |
24,602
+440
| +2% | +$144K | 0.02% | 107 |
|
|
2024
Q2 | $7.55M | Sell |
24,162
-637
| -3% | -$187K | 0.02% | 106 |
|
|
2024
Q1 | $7.05M | Sell |
24,799
-171
| -0.7% | -$50K | 0.02% | 106 |
|
|
2023
Q4 | $7.27M | Sell |
24,970
-804
| -3% | -$219K | 0.02% | 102 |
|
|
2023
Q3 | $6.93M | Sell |
25,774
-550
| -2% | -$137K | 0.02% | 100 |
|
|
2023
Q2 | $5.84M | Buy |
26,324
+24
| +0.1% | +$5.57K | 0.02% | 99 |
|
|
2023
Q1 | $6.36M | Buy |
26,300
+1,661
| +7% | +$408K | 0.02% | 99 |
|
|
2022
Q4 | $6.47M | Sell |
24,639
-75
| -0.3% | -$20.1K | 0.02% | 100 |
|
|
2022
Q3 | $5.57M | Buy |
24,714
+126
| +0.5% | +$30.5K | 0.02% | 107 |
|
|
2022
Q2 | $5.98M | Sell |
24,588
-1,238
| -5% | -$303K | 0.02% | 111 |
|
|
2022
Q1 | $6.25M | Buy |
25,826
+1,954
| +8% | +$449K | 0.02% | 114 |
|
|
2021
Q4 | $5.37M | Buy |
23,872
+9,204
| +63% | +$1.94M | 0.02% | 119 |
|
|
2021
Q3 | $3.12M | Sell |
14,668
-4,127
| -22% | -$950K | 0.01% | 133 |
|
|
2021
Q2 | $4.58M | Sell |
18,795
-1,334
| -7% | -$328K | 0.02% | 124 |
|
|
2021
Q1 | $5.01M | Sell |
20,129
-11,720
| -37% | -$2.8M | 0.02% | 105 |
|
|
2020
Q4 | $7.32M | Buy |
31,849
+1,213
| +4% | +$280K | 0.03% | 95 |
|
|
2020
Q3 | $7.79M | Sell |
30,636
-97
| -0.3% | -$24K | 0.03% | 90 |
|
|
2020
Q2 | $7.25M | Buy |
30,733
+5,299
| +21% | +$1.21M | 0.03% | 92 |
|
|
2020
Q1 | $5.16M | Buy |
25,434
+350
| +1% | +$76.4K | 0.03% | 94 |
|
|
2019
Q4 | $6.05M | Buy |
25,084
+1,023
| +4% | +$226K | 0.03% | 103 |
|
|
2019
Q3 | $4.66M | Sell |
24,061
-108
| -0.4% | -$20.7K | 0.02% | 104 |
|
|
2019
Q2 | $4.45M | Sell |
24,169
-27
| -0.1% | -$4.83K | 0.02% | 108 |
|
|
2019
Q1 | $4.6M | Sell |
24,196
-4,213
| -15% | -$805K | 0.02% | 111 |
|
|
2018
Q4 | $5.53M | Buy |
28,409
+463
| +2% | +$90.3K | 0.03% | 100 |
|
|
2018
Q3 | $5.79M | Hold |
27,946
| – | – | 0.03% | 104 |
|
|
2018
Q2 | $5.16M | Sell |
27,946
-2,426
| -8% | -$429K | 0.03% | 105 |
|
|
2018
Q1 | $5.18M | Sell |
30,372
-180
| -0.6% | -$33K | 0.03% | 104 |
|
|
2017
Q4 | $5.31M | Sell |
30,552
-4,513
| -13% | -$799K | 0.03% | 101 |
|
|
2017
Q3 | $6.54M | Hold |
35,065
| – | – | 0.03% | 97 |
|
|
2017
Q2 | $6.04M | Hold |
35,065
| – | – | 0.03% | 101 |
|
|
2017
Q1 | $5.75M | Sell |
35,065
-26,305
| -43% | -$4.37M | 0.03% | 103 |
|
|
2016
Q4 | $8.97M | Buy |
61,370
+26,779
| +77% | +$4.03M | 0.05% | 94 |
|
|
2016
Q3 | $5.77M | Sell |
34,591
-100
| -0.3% | -$16.9K | 0.03% | 108 |
|
|
2016
Q2 | $5.28M | Sell |
34,691
-2,784
| -7% | -$433K | 0.03% | 108 |
|
|
2016
Q1 | $5.62M | Buy |
37,475
+26,728
| +249% | +$3.97M | 0.03% | 102 |
|
|
2015
Q4 | $1.75M | Buy |
10,747
+126
| +1% | +$19.8K | 0.01% | 129 |
|
|
2015
Q3 | $1.47M | Hold |
10,621
| – | – | 0.01% | 130 |
|
|
2015
Q2 | $1.63M | Hold |
10,621
| – | – | 0.01% | 124 |
|
|
2015
Q1 | $1.7M | Hold |
10,621
| – | – | 0.01% | 126 |
|
|
2014
Q4 | $1.69M | Buy |
10,621
+4,920
| +86% | +$767K | 0.01% | 129 |
|
|
2014
Q3 | $801K | Hold |
5,701
| – | – | ﹤0.01% | 157 |
|
|
2014
Q2 | $675K | Buy |
5,701
+220
| +4% | +$25.5K | ﹤0.01% | 170 |
|
|
2014
Q1 | $676K | Sell |
5,481
-125
| -2% | -$15.2K | ﹤0.01% | 166 |
|
|
2013
Q4 | $640K | Buy |
+5,606
| New | +$638K | ﹤0.01% | 169 |
|
|
2013
Q2 | $543K | Buy |
+5,507
| New | +$571K | ﹤0.01% | 168 |
|
Other funds holding AMGN
VCM
VPM
Fayez Sarofim & Co's AMGN Position: Q1 2026 in Review
Fayez Sarofim & Co reduced its Amgen (AMGN) stake by 0.84% in Q1 2026, selling an estimated $156K and leaving 51,857 shares worth $18.2M. The position accounts for 0.05% of the portfolio, ranked #79.
Fayez Sarofim & Co first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Fayez Sarofim & Co held 51,857 shares of Amgen worth $18.2M as of Q1 2026.
- Fayez Sarofim & Co sold 438 Amgen shares in Q1 2026, an estimated $156K.
- Amgen made up 0.05% of Fayez Sarofim & Co's portfolio in Q1 2026, its #79 holding.
- Fayez Sarofim & Co first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.